Life sciences
By Nick Portch, Life Sciences, Equinix The race to develop new therapies has never been more urgent, or more complex. As life sciences companies increasingly turn to artificial intelligence (AI) to speed up drug discovery, one factor continues to determine success more than any other: access to data. But the very thing that could fuel [...]
The UK government has launched a £2bn life sciences strategy aimed at driving growth, speeding up innovation, and transforming NHS healthcare. Life sciences is one of eight priority sectors in the UK’s Industrial Strategy. The ten-year plan aims to boost an industry worth around £100bn and employing around 300,000 people. The strategy focuses on three [...]
By Sharon Lamb, Lorraine Maisnier-Boché, and Bella North, McDermott Will & Emory What new guidance from the UK Information Commissioner’s Office (ICO) on anonymisation means for healthcare and life sciences companies. Harnessing health data is a key priority for life sciences companies as it enables more effective scientific research, better tailored clinical trials and investigations, [...]
Scientists have identified two new families of drug molecules that could lead to future treatments for tuberculosis, the world’s second deadliest infectious disease after Covid-19. The compounds work by blocking an enzyme that tuberculosis bacteria use to convert cholesterol into energy, offering a potential way to starve the bacteria and combat the disease, which causes [...]
Oxford-based Ochre Bio, a biotechnology company developing RNA therapeutics for chronic liver disease, has appointed Dr Quin Wills as CEO. As Founder of Ochre, and previously CSO, Quin has been driving the company's innovative approach to late-stage liver disease – developing potential new therapeutics to target disease progression. Quin will now lead the company in [...]
Scientists are creating synthetic human DNA from scratch in a contentious project that could lead to new treatments for major illnesses. The research focuses on using lab-built DNA sections to develop therapies for autoimmune disorders, heart failure, viral infections and age-related diseases. These synthetic DNA strands are being inserted into skin cells to observe how [...]
LogicFlo today announces a $2.7 million seed funding round to scale its intelligent agent platform across the pharmaceutical, biotech, and medtech industries. The round was led by Lightspeed with participation from leading healthcare and enterprise AI investors. It will fund product expansion, team growth, and deeper deployments with global life sciences organisations, including a Fortune [...]
Odgers’ Chris Hamilton and Mike Drew examine how high-profile investment is reshaping executive leadership in longevity tech. The longevity tech sector was once a quiet corner of academic research. Now it has rapidly become one of the most exciting frontiers in innovation. Driven by soaring investment from billionaires and mission-led funds, the industry is redefining [...]
A world-first trial of a new scanner that could track the spread of brain cancer has begun in Aberdeen, involving glioblastoma patients. The field cycling imaging (FCI) scanner, which derives from MRI technology, operates at low and ultra-low magnetic fields and is being tested at the University of Aberdeen and NHS Grampian. Researchers say it [...]
Odgers’ Chris Hamilton and Mike Drew explain why the success of precision medicine will hinge on the development of critical leadership roles Precision medicine stands at the forefront of a transformative era in healthcare. As technological advancements in AI, genomics, and data analytics converge, the market for precision medicine is poised for exponential growth. By [...]
